Group One Trading
GTBP icon

Group One Trading’s GT Biopharma GTBP Stock Holding History

Group One Trading’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Hold
0
– -$1K – 8070
2022
Q1 		– Sell
-1
Closed -$2.21K – 7832
2021
Q4 		$3K Buy
+1
New +$3.74K ﹤0.01% 7783

Other funds holding GTBP

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFS
Baskin Financial Services Toronto, Ontario, Canada $1.27B AUM 9.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Group One Trading's GTBP Position: Q4 2022 in Review

Group One Trading held its GT Biopharma (GTBP) position steady in Q4 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7559.

Group One Trading first reported a position in GTBP in Q1 2022 and has held it in 2 quarters since. The position peaked at $52K in Q2 2022. 26 funds tracked by Wall St. Rank hold GTBP as of Q4 2022.

  • Group One Trading held 0 shares of GT Biopharma worth $0 as of Q4 2022.
  • Group One Trading left its GT Biopharma share count unchanged in Q4 2022.
  • GT Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q4 2022, its #7559 holding.
  • Group One Trading first reported a position in GT Biopharma in Q1 2022 and has held it in 2 quarters since.
  • Group One Trading's GT Biopharma position peaked at $52K in Q2 2022.
  • 26 funds tracked by Wall St. Rank held GT Biopharma as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.